WARD Glucose Pilot

WARD Glucose Pilot

Principal Investigator

Eske Kvanner Aasvang, MD, DMSc, Professor

Study design
Prospective study/cohort
Sample size
70 participants
Study sites

Rigshospitalet and Bispebjerg Hospital

Inclusion criteria
  • Adult patients (≥18 years) admitted to Rigshospitalet or Bispebjerg Hospital for major abdominal surgery (e.g. colonic resections, gastrectomy, hepatic resection etc.) or major orthopedic surgery (e.g. hip-fracture, hip and knee-arthroplasty) or major arterial vascular surgery (e.g. aortic aneurysm, iliac or femoral bypass etc.)
  • Estimated duration of surgery ≥1 hour and at least one expected overnight stay postoperatively

AND

● Type 1 diabetes (Clinically defined: insulin initiated at diabetes onset and treatment with multiple doses of insulin or continuous subcutaneous insulin infusion) (n=20)

OR

● Type 2 diabetes treated with insulin (Clinically defined: treatment with diet or oral antidiabetic drugs for at least 6 months before insulin was started) (n =20)

OR

● Type 2 diabetes treated with oral antihyperglycemic drugs and/or GLP-1 analogs (n=20)

OR

● No diabetes mellitus (excluded by an admission HbA1c <48 mmol/mol) (n=20)

Study procedures

A Dexcom G6 sensor measured glucose during surgery and for up to ten days afterwards. Patients and staff could not see the sensor readings and followed usual diabetes care. Researchers also recorded vital signs and 30-day complications.

Results

Seventy patients were included, with a median observation time of 4.0 days. CGM was recorded in median 96% of the observation time. The median daily duration of hypoglycemia was 2.5 minutes without significant difference between the 4 groups (A-D). Hypoglycemic events lasting ≥15 minutes occurred in 43% of all patients and 70% of patients with type 1 diabetes. Patients with type 1 diabetes spent a median of 40% of the monitoring time in the normoglycemic range 70 to 180 mg/dL and 27% in the hyperglycemic range >250 mg/dL. Duration of preceding hypo- and hyperglycemia tended to be longer in patients with serious adverse events, compared with patients without events, but these were exploratory analyses.

Outcome

Low glucose episodes lasting at least 15 minutes occurred in 43% of the 70 patients and in 70% of those with type 1 diabetes. Both low and high glucose occurred despite usual perioperative diabetes care.

Trial registration
NCT04473001

–  Read more